๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

17 recruiting trials

for HBV-HCC

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide NCT07429864n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma NCT07557251Phase 11 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: BRII-5395, Sintilimab, Bevacizumab HDV Screening Study NCT06889805n/a1 site๐Ÿ“ Hong Kong Grace Lai Hung Wong Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon ฮฑ-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study NCT07079150n/a2 sites๐Ÿ“ Xi'an๐Ÿ“ Xi'an First Affiliated Hospital Xi'an Jiaotong University ยท Tests: Peg IFN-ฮฑ-2b Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular Carcinoma NCT06961617Phase 11 site๐Ÿ“ Beijing Lion TCR Pte. Ltd. ยท Tests: LioCyx-M, HBV antigen-specific TCR-redirected T cells A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma NCT05417932Phase 1, Phase 26 sites๐Ÿ“ New York๐Ÿ“ New York๐Ÿ“ Hong Kong SCG Cell Therapy Pte. Ltd. ยท Tests: SCG101 National Liver Cancer Screening Trial NCT06084234Phase 419 sites๐Ÿ“ Los Angeles๐Ÿ“ Redwood City๐Ÿ“ Roseville University of Texas Southwestern Medical Center ยท Tests: GALAD, Liver Ultrasound with or without AFP Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon ฮฑ-2b Combined With NA. NCT06746701n/a4 sites๐Ÿ“ Guangzhou๐Ÿ“ Chenzhou๐Ÿ“ Hengyang Xiangya Hospital of Central South University ยท Tests: Peg-IFNฮฑ-2b combined with NA, Nucleotide Analogues Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC NCT06251115NA1 site๐Ÿ“ Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Scโ€ฆ ยท Tests: QY-1-T Antiviral Therapy for Patients With Liver Cancer After Surgery NCT05466565n/a1 site๐Ÿ“ Changsha Xiangya Hospital of Central South University New HBV Infection Biomarkers: Clinical Characterization and Impact on Management NCT06906016n/a1 site๐Ÿ“ Crรฉteil Assistance Publique - Hรดpitaux de Paris ยท Tests: Collection of blood samples for the study of HBV biomarkers Peg IFNฮฑ-2b Therapy for Unresectable Mid to Late Stage HBV-HCC NCT07769827NA1 site๐Ÿ“ Nanjing Jinling Hospital, China ยท Tests: Combined Peg IFNฮฑ-2b treatment group Liver Disease and Other Systemic Diseases NCT04525833n/a1 site๐Ÿ“ New Taipei City Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase NCT05661786n/a5 sites๐Ÿ“ Changzhou๐Ÿ“ Huai'an๐Ÿ“ Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Univeโ€ฆ ยท Tests: Observation, Antiviral treatment Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer NCT06658782n/a2 sites๐Ÿ“ Oxford๐Ÿ“ Bournemouth University of Oxford ยท Tests: non contrast enhanced MRI Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV) NCT04745403Phase 11 site๐Ÿ“ Singapore Lion TCR Pte. Ltd. ยท Tests: mRNA HBV/TCR T-cells
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy